ZA9711329B - New 4-(1-piperazinyl)benzoic acid derivatives, process for preparing them and their therapeutic applications. - Google Patents

New 4-(1-piperazinyl)benzoic acid derivatives, process for preparing them and their therapeutic applications.

Info

Publication number
ZA9711329B
ZA9711329B ZA9711329A ZA9711329A ZA9711329B ZA 9711329 B ZA9711329 B ZA 9711329B ZA 9711329 A ZA9711329 A ZA 9711329A ZA 9711329 A ZA9711329 A ZA 9711329A ZA 9711329 B ZA9711329 B ZA 9711329B
Authority
ZA
South Africa
Prior art keywords
piperazinyl
preparing
new
benzoic acid
acid derivatives
Prior art date
Application number
ZA9711329A
Other languages
English (en)
Inventor
Gerard Moinet
Gerard Botton
Liliane Doare
Micheline Kergoat
Didier Mesangeau
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of ZA9711329B publication Critical patent/ZA9711329B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
    • C07D215/08—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms with acylated ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
ZA9711329A 1996-12-18 1997-12-17 New 4-(1-piperazinyl)benzoic acid derivatives, process for preparing them and their therapeutic applications. ZA9711329B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9615588A FR2757158B1 (fr) 1996-12-18 1996-12-18 Nouveaux derives d'acide 4-(1-piperazinyl) benzoique, leur procede de preparation et leurs applications therapeutiques

Publications (1)

Publication Number Publication Date
ZA9711329B true ZA9711329B (en) 1998-06-24

Family

ID=9498818

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9711329A ZA9711329B (en) 1996-12-18 1997-12-17 New 4-(1-piperazinyl)benzoic acid derivatives, process for preparing them and their therapeutic applications.

Country Status (26)

Country Link
US (1) US6281215B1 (da)
EP (1) EP0937054B1 (da)
JP (1) JP2001506645A (da)
KR (1) KR20000069544A (da)
CN (1) CN1073102C (da)
AR (1) AR013889A1 (da)
AT (1) ATE218558T1 (da)
AU (1) AU726640B2 (da)
BR (1) BR9713587A (da)
CA (1) CA2275346A1 (da)
CZ (1) CZ218999A3 (da)
DE (1) DE69713128T2 (da)
DK (1) DK0937054T3 (da)
ES (1) ES2178039T3 (da)
FR (1) FR2757158B1 (da)
HU (1) HUP0000586A3 (da)
ID (1) ID23671A (da)
NO (1) NO312896B1 (da)
PL (1) PL334187A1 (da)
PT (1) PT937054E (da)
RU (1) RU2178786C2 (da)
SK (1) SK282841B6 (da)
TR (1) TR199901367T2 (da)
UA (1) UA56206C2 (da)
WO (1) WO1998027078A1 (da)
ZA (1) ZA9711329B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763334A1 (fr) * 1997-05-13 1998-11-20 Lipha Derives anthraniliques
GB0013346D0 (en) * 2000-06-01 2000-07-26 Glaxo Group Ltd Therapeutic benzamide derivatives
US6476046B1 (en) 2000-12-04 2002-11-05 Sepracor, Inc. Diazabicyclo[4.3.0]nonanes, and methods of use thereof
CN101417988B (zh) * 2007-10-24 2011-04-27 山东轩竹医药科技有限公司 双胍哌嗪类二肽酰肽酶ⅳ抑制剂
CN101781273B (zh) * 2009-01-21 2012-07-04 山东轩竹医药科技有限公司 含有胍基的二肽酰肽酶ⅳ抑制剂

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2346011A1 (fr) * 1976-02-02 1977-10-28 Orsymonde Acetanilido-piperazines
DE3139970A1 (de) * 1981-10-08 1983-04-28 Boehringer Mannheim Gmbh, 6800 Mannheim Neue carbonsaeurederivate, verfahren zu ihrer herstellung sowie diese verbindungen enthaltende arzneimittel
US5364849A (en) * 1989-04-22 1994-11-15 John Wyeth & Brother, Limited 1-[3 or 4-[1-[4-piperazinyl]]-2 arylpropionyl or butryl]-heterocyclic derivatives
FR2693722B1 (fr) 1992-07-16 1994-10-14 Meram Lab Dérivés de la N-cycloalkylpipérazine, procédé d'obtention et compositions pharmaceutiques les contenant.
GB9221931D0 (en) * 1992-10-17 1992-12-02 Wyeth John & Brother Ltd Piperazine derivatives
FR2707984B1 (fr) * 1993-07-23 1995-09-01 Adir Nouvelles pipérazines substituées, leur procédé de préparation et les compositions les contenant.
IT1278960B1 (it) * 1995-02-24 1997-12-02 Elitas S N C Di Belluzzi Lino Macchina tamponatrice per impregnare superficialmente pelli o simili.
US5723475A (en) * 1995-02-28 1998-03-03 Suntory Limited Arylpiperidine and arylpiperazine derivatives and medicament containing the same

Also Published As

Publication number Publication date
NO992968D0 (no) 1999-06-17
EP0937054A1 (en) 1999-08-25
PT937054E (pt) 2002-11-29
DE69713128D1 (de) 2002-07-11
ES2178039T3 (es) 2002-12-16
SK282841B6 (sk) 2002-12-03
US6281215B1 (en) 2001-08-28
TR199901367T2 (xx) 1999-10-21
AU726640B2 (en) 2000-11-16
EP0937054B1 (en) 2002-06-05
BR9713587A (pt) 2000-04-04
CA2275346A1 (en) 1998-06-25
NO312896B1 (no) 2002-07-15
AU5758298A (en) 1998-07-15
ATE218558T1 (de) 2002-06-15
FR2757158B1 (fr) 1999-04-02
FR2757158A1 (fr) 1998-06-19
RU2178786C2 (ru) 2002-01-27
KR20000069544A (ko) 2000-11-25
DK0937054T3 (da) 2002-09-16
DE69713128T2 (de) 2003-03-20
UA56206C2 (uk) 2003-05-15
AR013889A1 (es) 2001-01-31
HUP0000586A2 (hu) 2001-04-28
WO1998027078A1 (en) 1998-06-25
HUP0000586A3 (en) 2002-10-28
ID23671A (id) 2000-05-11
PL334187A1 (en) 2000-02-14
JP2001506645A (ja) 2001-05-22
CN1073102C (zh) 2001-10-17
SK78599A3 (en) 2000-03-13
NO992968L (no) 1999-08-17
CZ218999A3 (cs) 1999-09-15
CN1245494A (zh) 2000-02-23

Similar Documents

Publication Publication Date Title
HK1047575A1 (en) Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containingthe same.
HU9802422D0 (en) Substituted isoquinoline-3-carboxamide derivatives, process for producing them and their medical use
HK1044945A1 (en) 16-Halogen-epothilone derivatives, method for producing them and their pharmaceutical use.
ZA200109859B (en) 6-Alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations.
HUP0003073A3 (en) Benzenesulfonamide derivatives, process for producing them and their use as medicines
HUP0000658A3 (en) Sulphonamide derivatives, process for their preparation, and their use as medicaments
HUP0002718A3 (en) Piperazine derivatives, process for their preparation and medicaments containing the same
EE9700044A (et) Heteroarüüloksasolidinoonid, nende valmistamismeetod, kasutamine ravimite valmistamiseks ja nimetatud ühendeid sisaldavad ravimid.
PL345863A1 (en) Benzocycloheptenes, method for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments
ZA974574B (en) Novel guanidine derivatives process for their preparations and their use as pharmaceuticals.
HK1015789A1 (en) Propanolamine derivatives, processes for their preparation, pharmaceuticals comprising these compounds, and their use.
HUP9901312A3 (en) Novel alfa-hydroxylic acid derivatives, their production and use
PL350190A1 (en) Epothilon derivatives, method for the production and the use thereof as pharmaceuticals
HRP980258B1 (en) New triazole derivatives, process for the preparation thereof and pharmaceutical preparations containing them
HUP9901315A3 (en) New carboxzlic acid derivatives, their production and use
ZA988711B (en) New tetracycles, process for their production and pharmaceutical preparations containing these compounds.
HU9501041D0 (en) Peptide-boronic acid derivatives, process for producing them and pharmaceutical application thereof
NO972449D0 (no) Substituerte 2-arylkarbonyloksymetyl-1,2,5-tiadiazolidin-3-on 1,1 dioksidderivater og preparater og fremgangsmåte for anvendelse derav
ZA979059B (en) 10, 13, 15-Trioxatricyclo [9.2.1.1.<9.6>]-pentadecanone derivatives, method for the production thereof and medicaments containing these compounds.
HUP0100054A3 (en) Pyrimidinyloxi carboxylic acid derivatives, carrying amido side-chains, process for producing them, their use and medicaments containing the same
HK1046690A1 (en) Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments
ZA9711329B (en) New 4-(1-piperazinyl)benzoic acid derivatives, process for preparing them and their therapeutic applications.
NZ333916A (en) Process for preparing pyridine-2,3-dicarboxylic acid and use thereof
HUP0201863A3 (en) Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing the same
HUP9800472A3 (en) New benzoxazinedion derivatives, process for producing them and pharmaceutical copositions containing them